A Swedish study examining the potential use of NFLs and OCBs in CSF as biomarkers in patients with RIS revealed that high NFL levels in the CSF of RIS patients correlated with an increased risk of conversion to CIS or RRMS. This evidence concerns the gene NEFL and in situ carcinoma.